That Mounjaro transformation is real - I see the before-and-afters and they stick with me. You look like yourself again. But I keep thinking: what do your labs look like underneath? I’m on TRT three years now. Started at 218 total T, got it dialed in, run bloods every 12 weeks. My face didn’t snap back like Mounjaro would do it. Wife jokes i still look tired. Fair point. Here’s the thing: I know exactly what changed. Total T, free T, SHBG, hematocrit. I measured it. No guessing. Mounjaro hits the mirror by month two - you look alive again. But you don’t actually know what’s happening to ur liver or lipids until you check labs, and by then you’re committed. I did BPC-157 last spring for a shoulder thing. Eight degree ROM improvement, pain dropped. Could be the peptide, could be PT, probably both. But I tracked it bc I had a baseline. The Mounjaro glow is real. Get baseline bloodwork first. The transformation hits different when you know what’s underneath it.
pulling baseline bloods is the easy part - the hard part is actually using the data. Lipids elevated or hematocrit climbing? Mounjaro still wins on the mirror. Doesn’t fix the underlying risk. I watch guys grab one panel, see the transformation, then skip follow-ups because they feel fine. You’ve got the data - what’s your move if the numbers are bad?
Eight degrees ROM from BPC tracks close to what I got on my shoulder cycle - mine was 11 over six weeks of concurrent PT, and I genuinely still can’t separate those two variables without a cleaner baseline period. That’s the whole point you’re making and most people skip it because they start everything at once and then wonder why they can’t attribute anything. I use CareClinic’s weekly check-in reminders to log ROM and pain scores on the same day each cycle so dose timing and outcome data actually line up, which makes the conversation with my surgeon worth having instead of us both guessing.
edit: clarifying
The eight-degree ROM improvement with a documented baseline is exactly how the BPC conversation should go, so you’re clearly not someone who skips that step. Where I’d add a caveat: the panels most people run before starting tirz (lipids, liver, HbA1c) are genuinely useful, but they won’t tell you what’s happening to lean mass, which is the piece I find most concerning for anyone who trains. Standard bloods don’t flag muscle loss. A DEXA scan before starting gives you an actual comparison point at month six rather than “my bench dropped a bit” or “I look leaner but something feels off.” The mirror result and the metabolic markers both matter, but body composition data is what separates a good outcome from a concerning one, and most people don’t establish that baseline before they start.
The labs-before-mirrors framing is solid, but the lipid piece is where I’d add weight. Tirzepatide consistently moves LDL in one direction for some people and the opposite for others, and the variance is large enough that “I felt great at month two” tells you almost nothing about what’s actually happening. Twelve-week TRT labs is a reasonable cadence model here. Pre-start lipid panel plus repeat at week 12 is the minimum if you’re going in without clinical supervision.
Most guys don’t skip follow-ups because they don’t care. It’s that lipids climbing and hematocrit trending up don’t come w/ an instruction manual. Do you drop the dose? Stack something to offset it? That gap between having the data and knowing what to do with it’s where people actually stall.
The “gap between having the data and knowing what to do with it” is real, but I’d push back on framing it as the thing that makes people stall. Most guys I’ve seen freeze up aren’t confused about interpretation - they just don’t have a clinician who speaks this language. If your doc sees hematocrit at 52% and says “stop TRT immediately” without discussing dose adjustment or therapeutic phlebotomy, that’s a system problem, not a data literacy problem. The data gap is real, but it’s downstream of the access gap. That said, you’re right that raw numbers without context are near useless. Eight weeks into TRT I had no idea what to do with my SHBG until my prescribing doc walked me through it. More data without someone to interpret it just creates a different kind of paralysis.
Your BPC shoulder proves it: 8-degree ROM improvement, could be the peptide, could be PT, probably both - and you had a baseline. So baseline labs before Mounjaro won’t fully solve that either. Month zero labs look fine, month two they shift, now it’s “probably the drug, probably diet, maybe dosing.” Baseline’s still right. Isolation is just harder than bloodwork first.
Can’t isolate variables though. Labs at month 0 and month 2 still don’t tell you if the drug worked or the deficit. Most people stop measuring once they see results - baseline becomes tracking without insight into what actually changed.
Your BPC shoulder actually cuts against that logic, though. You had a baseline (ROM and pain) but stacked PT at the same time. Labs wouldn’t have isolated which one worked. Function is the measurement that counts.
mounjaro and bpc-157 are pretty different though. mounjaro’s going systemic so yeah, bloodwork matters there. but bpc is just localized repair, you genuinely feel it working or not in your shoulder. honestly i’m starting without baseline imaging anyway. idk, feels like you can track rom and pain instead.